Altimmune (ALT) EBITDA Margin Growth (5y) (2015 - 2025)
Altimmune (ALT) EBITDA Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Altimmune |
336.67 Mn |
336.67 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-10.44 Mn |
| Sep 30, 2025 |
-37.92 Mn |
| Jun 30, 2025 |
-44.33 Mn |
| Mar 31, 2025 |
-39.19 Mn |
| Dec 31, 2024 |
-46.54 Mn |
| Sep 30, 2024 |
-44.83 Mn |
| Jun 30, 2024 |
-49.32 Mn |
| Mar 31, 2024 |
-49.09 Mn |
| Dec 31, 2023 |
-8.42 Mn |
| Sep 30, 2023 |
-560,550.00 |
| Jun 30, 2023 |
-26.86 Mn |
| Mar 31, 2023 |
-9.49 Mn |
| Dec 31, 2022 |
-8.28 Mn |
| Sep 30, 2022 |
-118.23 Mn |
| Jun 30, 2022 |
-25.28 Mn |
| Mar 31, 2022 |
-5.94 Mn |
| Dec 31, 2021 |
-30,498.00 |
| Sep 30, 2021 |
10.26 Mn |
| Jun 30, 2021 |
-1.74 Mn |
| Mar 31, 2021 |
-165,217.00 |
